207 related articles for article (PubMed ID: 32391054)
1. Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Front Genet; 2020; 11():333. PubMed ID: 32391054
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
3. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
Wang T; Tian K; Ji X; Song F
Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
5. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
6. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
[TBL] [Abstract][Full Text] [Related]
7. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
[TBL] [Abstract][Full Text] [Related]
8. A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma.
Zhu X; Ma X; Wu C
Math Biosci Eng; 2021 Oct; 18(6):8559-8576. PubMed ID: 34814313
[TBL] [Abstract][Full Text] [Related]
9. An immune-related prognostic signature for predicting breast cancer recurrence.
Tian Z; Tang J; Liao X; Yang Q; Wu Y; Wu G
Cancer Med; 2020 Oct; 9(20):7672-7685. PubMed ID: 32841536
[TBL] [Abstract][Full Text] [Related]
10. Identifying and Validating of an Autophagy-Related Gene Signature for the Prediction of Early Relapse in Breast Cancer.
Min Y; Feng Y; Luo H; Hu D; Wei X; He D; Yin G; Fan S
Front Endocrinol (Lausanne); 2022; 13():824362. PubMed ID: 35250881
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer.
Zhou L; Yu Y; Wen R; Zheng K; Jiang S; Zhu X; Sui J; Gong H; Lou Z; Hao L; Yu G; Zhang W
Front Oncol; 2022; 12():863094. PubMed ID: 35619909
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
Wu M; Yuan H; Li X; Liao Q; Liu Z
Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
[No Abstract] [Full Text] [Related]
13. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
He M; Hu C; Deng J; Ji H; Tian W
World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival.
Zhang D; Zheng Y; Yang S; Li Y; Wang M; Yao J; Deng Y; Li N; Wei B; Wu Y; Zhu Y; Li H; Dai Z
Front Oncol; 2020; 10():596087. PubMed ID: 33489894
[TBL] [Abstract][Full Text] [Related]
15. A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.
Zhao Y; Zhang Y; Dai C; Hong K; Guo Y
Aging (Albany NY); 2022 Aug; 14(15):6169-6186. PubMed ID: 35939339
[TBL] [Abstract][Full Text] [Related]
16. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients.
Ma JY; Liu Q; Liu G; Peng S; Wu G
Aging (Albany NY); 2021 Jun; 13(12):16684-16695. PubMed ID: 34185683
[TBL] [Abstract][Full Text] [Related]
18. Systemic Analysis of the Prognosis-Associated Alternative Polyadenylation Events in Breast Cancer.
Zhang Y; Wang Y; Li C; Jiang T
Front Genet; 2020; 11():590770. PubMed ID: 33329736
[TBL] [Abstract][Full Text] [Related]
19. Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer.
Long G; Ouyang W; Zhang Y; Sun G; Gan J; Hu Z; Li H
Front Mol Biosci; 2021; 8():608369. PubMed ID: 33778002
[No Abstract] [Full Text] [Related]
20. A Novel TCGA-Validated, MiRNA-Based Signature for Prediction of Breast Cancer Prognosis and Survival.
Tian B; Hou M; Zhou K; Qiu X; Du Y; Gu Y; Yin X; Wang J
Front Cell Dev Biol; 2021; 9():717462. PubMed ID: 34589485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
